Quantifies glucocorticoid toxicity in Myasthenia Gravis, indicating the need for careful management.
This study aims to quantify glucocorticoid (GC)-related toxicity in Myasthenia Gravis (MG) patients using the Glucocorticoid toxicity index (GTI).
No takes yet. Share an insight, caveat, or question.
Beaudin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: